Sector: IT - Software - Information Technology
BSE Code: 532041
NSE Symbol: HINDBIO
ISIN: INE597C01021
📈 Hindustan Bio Sciences Q3 FY26: Revenue Hits ₹4003 Lakhs, PBT Turns Positive • Total revenue for Q3 FY26 was ₹4003 lakhs, with ₹3825 lakhs from operations and ₹178 lakhs from other income. • Profit before tax for Q3 FY26 was ₹820 lakhs, a significant improvement from a loss of ₹585 lakhs in Q3 …
📊 Hindustan Bio Sciences Ltd: Shareholding Correction & Update • Equity share capital corrected to ₹2,05,01,600 (1,02,50,800 shares of ₹2 each), not ₹10,25,08,000 as previously stated. • Acquirers are not part of the promoter/promoter group. • Total shares held increased from 510,000 (4.98%) to 5…
📈 Key Stakeholder Boosts Holdings in Hindustan Bio Sciences Ltd - Acquirers: Bosco Armando Menezes and Emily Bosco Menezes. - Target Company: Hindustan Bio Sciences Ltd (BSE listed, CIN: L26942TG1991PLC013564). - Pre-acquisition holdings: Bosco Armando Menezes (255,000 shares, 2.49%), Emily Bosco…
🔍 Key Shareholder Moves at Hindustan Bio Sciences Ltd - Bosco Armando Menezes acquired 15,000 additional shares (0.14% of total voting capital) via open market purchase. - Post-acquisition, Bosco holds 270,000 shares (2.63%) and Emily holds 255,000 shares (2.49%). - Combined holding now stands at…
📅 Hindustan Bio Sciences Ltd to Review Q3 FY26 Results on Jan 31 - Board meeting scheduled for January 31, 2026, at 02:00 PM in Hyderabad. - Agenda includes consideration of un-audited financial results for the quarter ended December 31, 2025. - Other matters may be discussed with the Chair's per…
Hindustan Biosciences: Zero Physical Share Transfer Requests as of Jan 2026 📊 - Hindustan Biosciences Ltd. disclosed compliance with SEBI regulations regarding physical share transfers. - As of January 6, 2026, no re-lodgment requests for physical shares were received or processed. - Registrar an…
Hindustan Bio Sciences Ltd. Update: Zero Shares Dematerialized in Q3 2025 📊 - No equity share certificates were received for dematerialization between 1 October 2025 and 31 December 2025. - Confirmation was received from Venture Capital and Corporate Investments Pvt. Ltd. (RTA). - Company details…
Hindustan Bio Sciences Ltd: December 2025 Share Transfer Update 📊 - Special re-lodgment window for physical share transfers (per SEBI Circular, July 2, 2025) remains active. - Zero requests received, processed, approved, or rejected as of December 5, 2025. - Processing time marked 'NA' due to no …
📊 Hindustan Bio Sciences Q2 FY2026 Results: Revenue at ₹33.50L, PBT ₹1.40L - Un-audited standalone Q2 FY2026 results approved by the Board. - Quarterly revenue: ₹33.50 lakhs; Profit before tax: ₹1.40 lakhs. - Half-year revenue: ₹34.36 lakhs; Profit before tax: ₹3.16 lakhs. - EPS for the quarter: …
📢 Hindustan Bio Sciences Opens Special Window for Share Transfer Requests (2025-2026) - Special re-lodgment window open from July 7, 2025, to January 6, 2026. - Applies only to transfer deeds lodged before April 1, 2019, that were rejected/unprocessed due to documentation issues. - Shareholders s…
Hindustan Bio Sciences Q1 2025 Results & Key Updates 📊 - Q1 2025 Revenue: ₹33.50 lakhs - Q1 2025 Expenses: ₹32.11 lakhs - Q1 2025 Profit: ₹1.40 lakhs - Q1 2025 EPS: ₹0.01 (Basic & Diluted) - Mr. Devanshu Ravinder Dange resigned as Company Secretary, effective July 31, 2025 - Mr. Shailendra Vyas a…